| 貨號 | 規格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|
S83546-5mg |
98.9% | ￥240.00 | 9 | - | - | - |
|
S83546-10mg |
98.9% | ￥360.00 | 10 | - | - | - |
|
S83546-50mg |
98.9% | ￥880.00 | 5 | - | - | - |
|
S83546-100mg |
≥98% | ￥1350.00 | 貨期：2-3天 | - | - | - |
|
S83546-200mg |
≥98% | ￥2400.00 | 貨期：2-3天 | - | - | - |
|
Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication (IC50: 50 nM).
| 產品描述： | Pleconaril is a capsid inhibitor used previously to treat enterovirus infections. Pleconaril is effective in inhibiting replication (IC50: 50 nM). | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | Antiviral;Virus Protease;VirusProtease;?Antiviral | ||||||||||||||||||||
| 參考文獻： | 1.Lacroix C, et al. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. Virol J. 2015 Jul 14;12:106. 2.Benschop KS, et al. Genetic and antigenic structural characterization for resistance of echovirus 11 to pleconaril in an immunocompromised patient. J Gen Virol. 2015 Mar;96(Pt 3):571-9. | ||||||||||||||||||||
| 溶解性： | DMSO:10 mg/mL,warmed | ||||||||||||||||||||
| 保存條件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京